Task: Answer the multiple-choice question.
Query: Which drug exhibits a 19.556% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) O=C(c1ccc(=O)oc1)N1CCOCC1
b.) COc1ccccc1NC(=O)N1CCCC1C(=O)Nc1ccc(NC(C)=O)cc1
c.) Cc1cc(=O)n2c3ccccc3n(CC(O)CN3CCN(Cc4ccccc4)CC3)c2c1C#N
d.) COc1ccccc1CC(=O)O/N=C(\N)Cc1cccc2ccccc12
e.) CCC(=O)N1CCc2cc(S(=O)(=O)NC(Cc3ccccc3)C(=O)O)ccc21
Answer: e. CCC(=O)N1CCc2cc(S(=O)(=O)NC(Cc3ccccc3)C(=O)O)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)N1CCc2cc(S(=O)(=O)NC(Cc3ccccc3)C(=O)O)ccc21
CCC(=O)N1CCc2cc(S(=O)(=O)NC(Cc3ccccc3)C(=O)O)ccc21
3-phenyl-2-[(1-propanoyl-2,3-dihydroindol-5-yl)sulfonylamino]propanoic acid